Kelly Paul Edward 4
4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Purchase
Common Stock
2025-11-05$2.20/sh+90,000$198,000→ 502,295 total
4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025
Common Stock